2019
DOI: 10.1002/jat.3840
|View full text |Cite
|
Sign up to set email alerts
|

Neuro‐ and hepatic toxicological profile of (S)‐2,4‐diaminobutanoic acid in embryonic, adolescent and adult zebrafish

Abstract: (S)‐2,4‐Diaminobutanoic acid (DABA) is a noncanonical amino acid often co‐produced by cyanobacteria along with β‐N‐methylamino‐l‐alanine (BMAA) in algal blooms. Although BMAA is a well‐established neurotoxin, the toxicity of DABA remains unclear. As part of our development of biocompatible materials, we wish to make use of DABA as both a building block and as the end‐product of enzymatically induced depolymerization; however, if it is toxic at very low concentrations, this would not be possible. We examined th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
3
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 34 publications
(47 reference statements)
2
3
2
Order By: Relevance
“…These results are supported by a previous dose response study using zebrafish larvae in which 300 μM was sufficient to produce signs of cardiotoxicity ( Ferraiuolo et al 2019 ). These results contrast with those from in vitro studies in which 2,4-DAB did not elicit an effect on viability at concentrations lower than 2000 μM or 1000 μM in human liver/brain cancer cells or mouse motoneuron-like cells, respectively ( Ferraiuolo et al 2019 ; Martin et al 2019 ). This distinction underscores the importance of studying toxin exposures in an in vivo context.…”
Section: Discussionsupporting
confidence: 83%
See 2 more Smart Citations
“…These results are supported by a previous dose response study using zebrafish larvae in which 300 μM was sufficient to produce signs of cardiotoxicity ( Ferraiuolo et al 2019 ). These results contrast with those from in vitro studies in which 2,4-DAB did not elicit an effect on viability at concentrations lower than 2000 μM or 1000 μM in human liver/brain cancer cells or mouse motoneuron-like cells, respectively ( Ferraiuolo et al 2019 ; Martin et al 2019 ). This distinction underscores the importance of studying toxin exposures in an in vivo context.…”
Section: Discussionsupporting
confidence: 83%
“…This distinction underscores the importance of studying toxin exposures in an in vivo context. Although exposure to BMAA or 2,4-DAB alone has previously been shown to cause morphological defects in larval zebrafish (Purdie et al 2009;Ferraiuolo et al 2019), we did not observe any significant morphological defects upon exposure to BMAA, AEG, or 2,4-DAB at 500 µM. This could be due to differences in zebrafish strain, embryo medium, exposure route, or observer analysis.…”
Section: Discussioncontrasting
confidence: 81%
See 1 more Smart Citation
“…The effects of 2,4-DAB on viability are dose dependent, as the lowest observed effect level was 250µM (data not shown). These results are supported by a previous dose response study using zebrafish larvae in which 300μM was sufficient to produce signs of cardiotoxicity (Ferraiuolo et al 2019). These results contrast with those from in vitro studies in which 2,4-DAB did not elicit an effect on viability at concentrations lower than 2000µM or 1000µM in human liver/ brain cancer cells or mouse motoneuron-like cells, respectively (Ferraiuolo et al 2019;Martin et al 2019).…”
Section: Discussionsupporting
confidence: 82%
“…This distinction underscores the importance of studying toxin exposures in an in vivo context. Although exposure to BMAA or 2,4-DAB alone has previously been shown to cause morphological defects in larval zebrafish (Ferraiuolo et al 2019;Purdie et al 2009), we did not observe any significant morphological defects upon exposure to BMAA, AEG, or 2,4-DAB at 500µM. This could be due to differences in zebrafish strain, embryo medium, exposure route, or observer analysis.…”
Section: Discussioncontrasting
confidence: 74%